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The secreted TGFβ factor Lefty antagonizes Nodal
signaling during vertebrate embryogenesis, but how
it does so has been a mystery. Recent analyses have
elucidated the molecular mechanisms underlying this
function of Lefty. 
The Lefty proteins of the transforming growth factor β
(TGFβ) superfamily are essential for mesendoderm
development, gastrulation and left–right patterning
during vertebrate embryogenesis [1]. Unlike other
TGFβs, Lefty does not function via receptor-mediated
Smad-dependent signaling, but rather by antagoniz-
ing the signaling of at least one other TGFβ subfamily,
the Nodals [1]. A balance between Lefty and Nodal
activity underlies the proper execution of many
developmental processes, as evidenced by the severe
and often fatal phenotypes observed in Lefty- or
Nodal-deficient embryos [1]. Multiple mechanisms by
which Lefty antagonizes Nodal signaling have been
suggested, yet direct evidence for such mechanisms
has been elusive [2–5]. Similarly, the proposed ability
of Lefty to antagonize Nodal-independent signaling
remains unconfirmed [3,5–10]. Two recent studies
[11,12] have addressed these issues.
Is Lefty a Nodal-Specific Antagonist or an Inhibitor
of Multiple TGFβ Signals?
The ability of Lefty to antagonize Nodal signaling has
been strongly supported by two key observations. First,
the loss of Lefty activity results in an expansion of
Nodal signaling in vertebrate embryos [1]. Conversely,
the upregulation of Lefty activity leads to a reduction in
Nodal signaling [1], as compellingly illustrated by the
identical phenotypes of zebrafish that overproduce
Lefty and those genetically incapable of Nodal signal-
ing [4,5,13]. Lefty has also been implicated in the antag-
onism of many other TGFβ signaling pathways —
Activin [5,8,9], bone morphogenetic proteins (BMPs)
[3,7,10], TGFβ1 [3], Vg1 [7] — as well as the Wnt signal-
ing pathway [6], though the evidence supporting these
cases is less substantial than that for Nodal.
Using a Smad2-responsive luciferase reporter assay
in cell culture and zebrafish embryos, Chen and Shen
[11] and Cheng et al. [12] found that Lefty antagonizes
Nodal and Vg1 signaling, but not Activin or TGFβ1
signaling. Cheng et al. [12] additionally showed that, in
zebrafish embryos, Lefty antagonized the ectopic
induction of goosecoid by Nodal and Vg1 overexpres-
sion, but not by Activin. These results suggested 
that Lefty might specifically antagonize EGF-CFC 
co-receptor-dependent signaling, as such co-receptors
are essential to Nodal/Vg1 signaling [1,14].
The EGF-CFC proteins — Cripto, Cryptic, FRL-1 and
Oep — are extracellular glycosylphosphotidylinositol
(GPI)-linked factors that interact with Nodal and Vg1/GDF
(growth and differentiation factor) ligands and facilitate
the ability of these ligands to bind and activate type I
(Alk4/7)–type II (ActRIIA/B) transmembrane receptor
complexes (Figure 1A) [1,15]. As Lefty only antagonized
EGF-CFC-dependent signaling, Cheng et al. [12] tested
whether Lefty genetically interacts with EGF-CFCs. They
found that overexpression of EGF-CFCs antagonized the
phenotypic effects of Lefty overexpression.
These correlations between Lefty antagonism and
EGF-CGC-dependent signaling led both groups to test
whether Lefty biochemically interacts with the EGF-
CFC–type I–type II receptor signaling complex. They
found that Lefty co-immunoprecipitated with the EGF-
CFC co-receptor, but not with the type I or II receptors
[11,12]. Furthermore, Lefty competed with Nodal, 
preventing it from binding EGF-CFCs [11,12]. This
competitive binding likely enables Lefty to antagonize
Nodal signaling by preventing the obligatory interaction
between EGF-CFCs and the type I–type II receptor
complex (Figure 1B,C) [11,12].
Does Lefty Affect EGF-CFC-Dependent
Mechanisms beyond TGFβ Signaling?
The initial descriptions of the Xenopus and zebrafish
Leftys characterized them as Activin antagonists [5,8,9].
The EGF-CFC factor Cripto can antagonize Activin sig-
naling by interacting with Activin and its receptor
complex [15]. By binding Cripto, Lefty might alter or
inhibit the interaction of Activin with Cripto and subse-
quently influence Activin signaling. However, Chen and
Shen [11] and Cheng et al. [12] found that, in the pres-
ence of EGF-CFCs, Lefty cannot diminish Activin sig-
naling, as measured by a Smad2-responsive luciferase
reporter [11,12]. The previous observations that mis-
expression of Activin or Activin receptors suppresses
Lefty gain-of-function phenotypes might be explained
by the fact that Activin can activate TGFβ signaling in
an EGF-CFC-independent manner and thereby circum-
vents the Lefty–EGF-CFC-mediated reduction of
Nodal/Vg1/GDF signaling.
Cripto can also activate Akt and mitogen-activated
protein (MAP) kinase pathways independently of TGFβ
signaling [1,15]. Interestingly, Ulloa et al. [16] have
shown that Lefty can activate MAP kinase as well.
These observations suggest that Lefty–Cripto interac-
tions might play a role in MAP kinase activation (Figure
1B,C). Additional studies are necessary to clarify
whether Lefty–EGF-CFC complexes are capable of
direct intracellular signaling.
Does Lefty Bind TGFβs other than Nodal?
Leftys were predicted to be incapable of forming
homodimers or heterodimers with other TGFβ ligands,
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as they lack the canonical cysteine residue that
stabilizes TGFβ dimers [2,5]. However, Chen and Shen
[11] found that Lefty and Nodal can directly interact in
solution, revealing a second potential mechanism of
Lefty-dependent Nodal antagonism. This interaction
likely antagonizes Nodal signaling by preventing Nodal
from binding its receptor complex (Figure 1C,D), as evi-
denced by the ability of Lefty to abrogate the co-
immunoprecipitation of Nodal with the type II receptor
[11]. Alternatively, Lefty–Nodal interactions might affect
the endoproteolytic processing of Nodal and subse-
quently impact Nodal activity.
Many studies have suggested that Lefty can
antagonize TGFβ signaling pathways other than
Nodal. The ability of Lefty to inhibit Vg1/GDF, but not
Activin or TGFβ1, signaling was discussed above.
Lefty has also been implicated in BMP signaling
[3,7,10]. In light of the discovery of Lefty–Nodal
interaction, can Lefty biochemically interact with
Vg1/GDFs, BMPs or itself? If so, how will these
interactions affect signaling? The identification of the
domains in Nodal and the EGF-CFCs necessary for
Lefty binding will allow the ‘in silico’ selection of other
candidates for Lefty interaction.
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Figure 1. Direct interaction of Lefty with
EGF-CFCs and Nodal antagonizes Nodal
signaling. 
(A) Nodal signaling is an EGF-CFC-depen-
dent process. The binding of Nodal by
EGF-CFC co-receptors facilitates the
interaction of Nodal and the type I–type II
Nodal receptor complex. This extracellular
interaction leads to the Smad-dependent
upregulation of Nodal response genes.
(B–D) Lefty inhibits Nodal signaling by pre-
venting the association of Nodal with the
type I–type II receptor complex. This inhi-
bition results from the direct interaction of
Lefty with the EGF-CFC co-receptor (B,C)
or with Nodal (C,D). Additionally, both
Lefty and EGF-CFCs can activate MAP
kinase signaling, suggesting a possible
role for Lefty–EGF-CFC interactions in this
process (B,C). For simplicity, Lefty and
Nodal are depicted as monomers.
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Figure 2. Lefty–Nodal reaction–diffusion
establishes Nodal signaling gradients.
The Turing reaction–diffusion model
hypothesizes that interactions between an
activator and an inhibitor control signaling
gradients within a field of cells and sub-
sequently pattern them. Nodal–Lefty inter-
actions exemplify several aspects of this
model [1,17]. First, the activator (Nodal)
activates its own production. Second, the
activator (Nodal) activates its inhibitor
(Lefty). Third, the inhibitor (Lefty) blocks
activator (Nodal) autoactivation. Fourth,
the inhibitor (Lefty) acts at a distance to
restrict the effective range of the activator
(Nodal). (A) Schematic illustration of
Lefty–Nodal reaction–diffusion. The black
squares represent a field of cells within a
Nodal-signaling gradient. The left-most
cell is the Nodal/Lefty point source, and
the first three properties of Nodal–Lefty
reaction–diffusion are depicted within.
The red lines and bars emanating from
this cell depict the fourth property, the
long-range activity of Lefty. The green
lines and arrows depict Nodal signaling.
Note that Lefty is depicted to act farther
from its source than Nodal [2,17]. Nearest to the point source, Nodal concentrations predominate over those of Lefty, resulting in high-
level Nodal signaling. Farther from the source, the ratios of Lefty to Nodal increase and result in low-level Nodal signaling. Farthest
from the source, Lefty concentrations predominate and effectively inhibit Nodal signaling. (B) Graphic depiction of the Nodal (green
line) and Lefty (red line) concentration gradients in A.
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Do Lefty–Nodal–EGF-CFC Interactions Shape
Nodal Signaling Gradients?
The interactions between Lefty and Nodal have been
proposed to resemble a Turing reaction–diffusion
model, in which an activator (Nodal) and an inhibitor
(Lefty) are emitted from a point source to pattern fields
of cells during development (Figure 2) [1,17]. One
postulate of this model is that the inhibitor acts over a
long range to restrict the effective range of the activa-
tor. Accordingly, several groups [2,6,17] have shown
that Lefty acts over long distances to inhibit long-range
Nodal signaling. The ability of the membrane-bound
EGF-CFCs to physically interact with Nodal and Lefty
suggests that EGF-CFCs might directly modulate the
range of these secreted ligands. The challenge will be
to experimentally separate the known role of EGF-CFCs
in Nodal signal transduction from potential roles in the
regulation of Lefty and Nodal diffusion.
Are Lefty–EGF-CFC Interactions Involved in
Cancer?
Cripto overexpression has been strongly implicated in
tumorigenesis, but it is unclear how Cripto contributes
to this process [15]. Additionally, Oep has recently been
shown to affect cell migration, a process integral to
metastasis [18]. Might Lefty–EGF-CFC interactions facil-
itate or inhibit oncogenesis? Alterations in Lefty expres-
sion have been detected in multiple tumor types [19,20],
and Ulloa and Tabibzadeh [3] briefly noted that intro-
duction of Lefty to tumor cells reduces tumor growth in
nude mice. The ability of Leftys and EGF-CFCs to affect
TGFβ and MAP kinase signaling, both of which are inti-
mately involved in oncogenesis, strongly suggests that
future studies on the role of EGF-CFCs in cancer should
explore possible functions for Lefty as well.
Chen and Shen [11] and Cheng et al. [12] have
provided two key insights into the molecular mecha-
nisms governing the Lefty-dependent antagonism of
TGFβ signaling. First, Lefty appears to exclusively
antagonize EGF-CFC-dependent TGFβ signaling
(Nodal/Vg1/GDF). Second, this antagonism is achieved
via interaction of Lefty with EGF-CFC co-receptors
(Cripto, Cryptic, Oep) or Nodal. These interactions pose
a number of interesting questions, as outlined above,
that need to be addressed if the ‘cryptic’ mechanisms
of Lefty function and diffusion are to be fully ‘decoded’.
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